March 2015


NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Rolling All Faculty Non-federal Clinical Studies

Investigator-initiated Research Grants

Supports innovative and unique clinical trials that have the potential to immediately impact the lives of cancer patients in a positive way. Looking for outstanding clinical treatment ideas and are driven to deliver new and better treatment options by designing novel, new, and/or pilot projects distinctly removed from currently funded research projects.
Due Dates: Rolling Submission of Letters of Intent
Amount & Project Period: Dollars and Length are not specified
Eligibility: New and established investigators
Contact: Linda Nolan (x6071)
Links: Funding Process  Ι  Apply for a Cancer Research Grant


March 01 Graduate Students Non-federal Bone  Marrow Failure

Aplastic Anemia & MDS International Foundation (AA&MDSIF)

Summer Fellowship Grant Program

Will offer students an opportunity to engage in research under the supervision of an established institution  Students will learn valuable skills, gain experience and develop an interest in the science of bone marrow failure disease
Due Dates: February 26 (OSR) Ι March 1 (Sponsor)
Amount & Project Period: $5,000 - 10 week fellowship for the summer of 2015
Eligibility: Medical students and graduate students, in the biological sciences currently enrolled in a U.S. graduate program in the biomedical sciences, medical school or in an MD/PhD program
Contact: Linda Nolan (x6071)
RFA Link: Summer Fellowship Program Application


March 01 See Below Non-federal Melanoma

Melanoma Research Foundation - 2015 Research Awards

Due Dates: February 26 (OSR) Ι March 01 (Sponsor)
Contact: Linda Nolan (x6071)
Links: Request for Proposals 2015 Ι Application and Review Process

Career Development Awards

Researchers who are beginning a research career focused on melanoma and have not yet established strong federal funding for their research are eligible.   Use of relevant genetic models and human derived tumor samples is highly encouraged
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Postdocs & Jr. Faculty

Established Investigator Awards (EIA)

To established melanoma researchers, or senior researchers working in closely related fields wishing to move into melanoma research.  Use of relevant genetic models and human derived tumor samples is highly encouraged.
Amount & Project Period: $100,000/year - 2 years
Eligibility: Associate Professor or higher

2015 Team Awards

Teams of basic scientists and clinicians to address an unmet clinical need   Use of relevant genetic models and human derived tumor samples is required. Must address 1 of the Specific Topic Proposals (STPs) identified below:
1.  Prevention: Development of models and biomarkers.
2.  Identifying mechanisms and respective therapeutic strategies in less common molecular subsets of melanoma.
3.  Metastases: Dormancy and metastatic progression.
4.  CNS Metastases: Development of markers of risk and rational therapeutic approaches.
5.  Response to treatment: Mechanisms and respective biomarkers for predicting response and for monitoring therapeutic response.
6.  Resistance: Intrinsic/Innate/Primary resistance to immunotherapies in melanoma.
Amount & Project Period: $250,000/year - 2 years
Eligibility: Associate Professor or higher
U01 NIDDK
National Institute of Diabetes and Digestive and Kidney Diseases
March 02 (LOI) All Faculty Federal Pancreatic

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC -CCs)

For establishment of up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes.
Due Dates: March 02 (Letter of Intent) Ι March 31 (OSR) Ι April 02 (Sponsor)
Amount & Project Period: $270,000/year (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: RFA-DK-14-027
U01 NIDDK
National Institute of Diabetes and Digestive and Kidney Diseases
March 02 (LOI) All Clinical  Faculty Federal Pancreatic

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordination and Data Management Center (CSCPDPC- CDMC)

For establishment of Coordination and Data Management Center (CDMC) for up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes.
Due Dates: March 02 (LOI) Ι March 31 (OSR) Ι April 02 (Sponsor)
Amount & Project Period: $1M (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: RFA-DK-14-028
Cooperative Agreement ONC/DHHS
Office of the National Coordinator of Health Information Technology

NEW
March 02 (LOI) All Ranks Federal Community Health

Office of the National Coordinator of Health Information Technology Community Health Peer Learning Program (CHP)

The purpose is to address health challenges at the population level through a community-based collaborative approach.  During initial phase of program, awardee will release a call for applications to identify and select up to ten (10) communities across the care management continuum to participate in the CHP. During second phase, selected communities will complete a peer learning program

ONC will conduct an informational session to provide information related to this FOA.  Further details - including date, time, and instructions for joining - are available at: http://healthit.gov/newsroom/community-health-peer-learning-program
Due Dates: March 02 (Letter of Intent)
Applications:  April 02 (OSR) Ι April 06 (Sponsor)
Amount & Project Period: $1,700,000 - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: CLP-CL-15-001


March 03 (LOI) All Ranks Non-federal HIV

amfAR, The Foundation for AIDS Research
Impact Grants Exploring HIV Persistence and Eradication

Availability of funding to support research relevant to exploring HIV persistence and the potential for HIV eradication  Priority will be given to projects with a clear pathway to development of an implementable intervention in humans Impact Grants support in-depth development of concepts where preliminary data have indicated genuine promise in curing HIV and should include basic, animal and clinical (in vivo or ex vivo) research, and collaborations with other institutions.
     Must request log-in credentials no later than 3:00 PM ET on Friday, February 27, 2015.  
Due Dates: March 03 (Letter of Intent)
Hardcopy of Signed Face Page By Mail: Tuesday, March 24, 2015 Invited Applications:  March 26 (OSR) Ι March 30 (Sponsor)
Amount & Project Period: $2,000,000 (TOTAL) - 4 years
Eligibility: Must hold a doctoral-level degree
Must hold a faculty-level position
Must be affiliated with the applicant institution
Contact: Linda Nolan (x6071)
RFA Link: RFP


NEW
March 06 (LOI) Postdocs/Jr. Faculty Non-federal Career Development

Thrasher Research Fund
Early Career Awards  

To encourage development of medical research in child health by awarding small grants to new researchers  The Fund is open to a variety of research topics important to children's health.  Both incidence and severity are considered when determining the significance of a problem being studied.
Due Dates: March 06 (Noon MST) Concept Paper
Invited Submissions:  April 16 (OSR) Ι April 20 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: Post-doctoral researchers who received doctoral degree <3 years prior to date of submission of Concept Paper
Physicians in residency/fellowship training program, or completed that program <1 year before date of submission of Concept Paper
A new investigator holding an NIH K award or a Clinical and Translational Science Award (CTSA) is not eligible
Each applicant must have a mentor. Qualifications and experience of the mentor will be considered in evaluating the application. There are no restrictions with regard to citizenship.
Contact: Linda Nolan (x6071)
Link: Early Career Award Guidelines
R01 NCI

March 06 All Ranks Federal Translation of Technologies

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

Encourages applications from research partnerships formed by academic and industrial investigators, to accelerate translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging designed to solve a targeted cancer problem  Will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work.
Due Dates: March 04 (OSR) Ι March 06 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-075




Spring 2015 Cycle
March 06 (LOI) All Ranks Non-federal PCOR

Patient-Centered Outcomes Research
Institute Spring Cycle 2015

Due Dates: March 06 (Letter of Intent)
Applications: May 01 (OSR) Ι May 05 (Sponsor)
Eligibility: All Ranks
Contact: Scott Mears - 1397

Improving Methods for Conducting Patient-Centered Outcomes Research

To address gaps in methodological research relevant to conducting patient-centered outcomes research (PCOR) 
Amount & Project Period: $750,000 (Direct Costs) - 3 years
Link: Improving Methods

Addressing Disparities

To fund comparative effectiveness research (CER) studies evaluating or comparing new and/or enhanced interventions to reduce or eliminate disparities in health and healthcare. Studies should focus on overcoming barriers that may disproportionately affect outcomes of specific groups of patients, or identify best practices for sharing results and information about patient-centered research across patient groups. 
Amount & Project Period: $1.5M (Direct Costs) - 3 years
Link: Addressing Disparities

Communication and Dissemination Research

For projects addressing critical knowledge gaps in communication and dissemination - of research results to patients, caregivers, and clinicians, as well between patients, caregivers, and clinicians
Amount & Project Period: $1.5M (Direct Costs) - 3 years
Link: Communication and Dissemination

 Assessment of Prevention, Diagnosis, and Treatment Options

To provide information that would inform critical decisions that face patients and caregivers, clinicians, policy makers, and healthcare system leaders. These decisions must be consequential and be occurring now in the absence of sound evidence about the comparative effectiveness of alternative approaches 
Amount & Project Period: $2.0M (Direct Costs) - 3 years
Link: Assessment of Prevention

Improving Healthcare Systems

To study comparative effectiveness of alternate features of healthcare systems (e.g., innovative technologies, incentive structures, service designs) intended to optimize quality, outcomes, and/or efficiency of care for patients served, and have most potential for sustained impact and replication within and across healthcare systems
Amount & Project Period: $5.M (lge. studies) - 5 years  Ι  $1.5M (small studies) - 3 years
Link: Improving Healthcare Systems

Large Pragmatic Studies to Evaluate Patient-Centered Outcomes 

Due Dates: May 01 (Letter of Intent)
Applications:  July 29 (OSR) Ι July 31 (Sponsor)
Amount & Project Period: TBD - 5 years
Link: Large Pragmatic Studies to Evaluate
R25 NIH
NCI is a participating Institute
NEW
March 07 (LOI) All Ranks Federal BDK2

NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science

To support educational activities that will enhance diversity of the biomedical, behavioral, and clinical research workforce.  FOA will support creative educational activities with a primary focus on research experiences and curriculum development
Due Dates: March 07 (Letter of Intent)
Applications:  April 03 (OSR) Ι April 07 (Sponsor)
Amount & Project Period: $200,000/year (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-MD-15-005


&

March 09 Postdocs Non-federal Career Development

Society for Immunotherapy of Cancer - in partnership with Merck
2015 SITC-Merck Cancer Immunotherapy Clinical Fellowship Award

Funding support for a project in related to development and application of cancer immunotherapy in a unique clinical research area
Due Dates: March 5 (OSR) Ι March 09 (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: MD or combined MD/PhD degree as a  postdoc, resident, research scientist or comparable position
SITC member in good standing at time of Submission
75% effort for this project
Contact: Linda Nolan (X6071)
Link: Fellowship Information
R01 Multiple Agencies

March 09 All Ranks Federal Multi-scale Models

Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research

NCI is interested in supporting development of predictive multi-scale models of cancer processes.  Models may be designed to elucidate basic mechanisms underlying cancer initiation and progression and/or address important translational, clinical or epidemiological questions related to cancer risk, prevention, diagnosis and treatment.
Due Dates: Letter of Intent due 30 days prior to due date
March 05 (OSR) Ι March 09 (Sponsor)
Amount & Project Period: <$500,000/year (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-085
U24 NIH
NCI is a participating Institute

NEW
March 14 (LOI) All Ranks Federal Brain Cognitive Development

Adolescent Brain Cognitive Development (ABCD) Study
(3 Funding Opportunity Announcements)

Due Dates: March 14 (Letter of Intent)
Applications:  April 10 (OSR) Ι April 14 (Sponsor)
Amount & Project Period: Budgets are not limited – 5 years
Contact: Linda Nolan (x6071)

Coordinating Center

FOA solicits applications for an overall Coordinating Center to provide organizational framework for management, direction, and overall coordination of national multi-site consortium.  Will coordinate interactions of individual Research Project Sites and Data Analysis and Informatics Center. Coordinating Center will be responsible for standardization of protocols, training of staff, and testing of inter-rater reliability of core neuropsychological, clinical, and other phenotypic assessments to make sure administration of these measures is consistent across research sites.
Eligibility: All Ranks - PI/PD should have multidisciplinary expertise and working knowledge of resources, methods, and logistics required in support of the objective and research questions described in the FOA.  Minimum effort for a single PD/PI is 35% effort per year, and if MPIs, each multi-PD/PI must commit at least 20% per year. Consortium Coordinator(s) cannot be PD/PI on another component of consortium
RFA Link: RFA-DA-15-014
U01 NIH

Research Project Sites

Multi-site research project sites from a group of investigators (both w/in and across institutions) or from a single site whose scientific and technical expertise will allow them to address the objective and research questions described in RFA
Research project site will be responsible for subject recruitment & retention, behavioral assessments, biospecimen collection, and neuroimaging. In addition to addressing primary objective of consortium, each research project site will be allowed to pursue additional aims and objectives provided they remain secondary to overall consortium objective
Eligibility: All Ranks - supports, but does not require, linked applications
RFA Link: RFA-DA-15-015
U01 NIH

Data Analysis and Informatics Center

The Collaborative Research on Addiction at the NIH (CRAN) intends to jointly fund the Adolescent Brain Cognitive Development (ABCD) Study Consortium.  This FOA solicits applications for one central Data Analysis and Informatics Center (DA&IC) to coordinate and centralize the data analysis, integration, harmonization, sharing, and informatics across research project sites in support of the objective and research questions described in FOA  The DA&IC will oversee and manage standardization of data collection procedures; provide technical support; ensure quality control; perform integrative data analysis; and coordinate data storage and data sharing activities.
Eligibility: All Ranks
RFA Link: RFA-DA-15-016

NEW
March 15 (Concept Paper) All Ranks Non-federal Pembrolizunab

Oncology Merck Investigator Studies Program (MISP) Concept Proposals

 1.    Novel regimens using pembrolizumab
 2.    Maintenance(Pembrolizumab post induction with BRAF/MEK, etc.)
 3.    Observational studies evaluating or assessing characteristics of patients treated
         w/pembrolizumab
 4.    Studies that describe innovative programs and methods for studying survivorship of
         patients
 5.    Studies that identify, from patient's perspective, cancer symptoms of greatest importance in
         patients with advanced cancers
Due Dates: March 12 (OSR) Ι March 15 (Sponsor)
Invited Submissions:  W/in 6 weeks of notification of concept approval
Amount & Project Period: $1,000,000  (Performance period dependent on study proposed)
Eligibility: All Ranks
Contact: Linda Nolan (X6071)
Links: Merck Investigator Studies Program
Visiontracker (online research system)
Concept Templates


NEW
March 16 (Pre-app) All Ranks Non-federal Healthcare-Vulnerable Populations

Rita and Alex Hillman Foundation
Innovations in Care

To advance leading edge, nursing driven models of care that will improve health and health care of vulnerable populations, including  economically disadvantaged, racial & ethnic minorities, LGBQT, homeless, rural populations, and other groups that encounter barriers to accessing health-care services.
Due Dates: March 16 (Pre-application)
Invited Submissions:  June 11 (OSR) Ι June 15 (Sponsor)
Amount & Project Period: $600,000 (Total) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: Overview Ι RFP


March 17 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award

Supports all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention
Due Dates: March 12 (OSR) Ι March 16 by 4:00pm(Sponsor)
Amount & Project Period: Level I Funding: $50,000/year plus $2,000 for expenses
Level II Funding: $60,000/year plus $2,000 for expenses
Award duration:  3 years
Eligibility: Degree conferred April 15, 2014 - March 16, 2015 (MD, PhD, MD/PhD, DDS, DVM or equiv.)
Foreign candidates may apply to do research only in the US
Contact: Linda Nolan (X6071)
Link: Fellowship Award Application Guidelines


NEW
March 17 (Pre-app) Established Investigators Non-federal Myelodysplastic Syndromes

Taub Foundation  
Grants program for MDS Research

High-impact, innovative translational research on underlying causes of MDS and advancement of treatment & prevention.  Program specifically focuses on MDS research, exclusive of AML and MPN  Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)
Full applications will be invited and due mid-August
Amount & Project Period: $200,000/year (Total) - 3 years
Eligibility: Independent investigators w/institutional support & laboratory space
U.S. citizenship not required; visa documentation not required
Contact: Linda Nolan (x6071)
Link: Taub Foundation Grants Program for MDS Research


March 17 Established Investigators Non-federal Multiple Myeloma

Multiple Myeloma Research Foundation (MMRF)
Senior Research Awards

To accelerate development of therapeutic approaches for myeloma; may include proposals in basic science, validation, or clinical research
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)
Amount & Project Period: $100,000/year (TOTAL) - 2 years
Eligibility: Established Investigators w/documented experience in blood cancer research or in research areas that are pertinent to multiple myeloma
Contact: Linda Nolan (x6071)
Links: MMRF Research Grants Ι 2015 Program Guidelines
R21 NIH
March 17 All Ranks Federal Molecular Analysis Technology

Innovative Molecular Analysis Technologies for Cancer Research

Emphasis of this FOA is on supporting development of novel molecular and cellular analysis capabilities with a high degree of technical innovation with potential to significantly affect and transform investigations exploring  molecular and cellular basis of cancer
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-002
R33 NIH

March 17 All Ranks Federal Molecular Analysis Technology

Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research

Projects on advanced development of emerging molecular and cellular analysis technologies and validation in an appropriate cancer-relevant biological system Proof-of-principle of proposed technology or methodology has been established and supportive preliminary data are available   Proposal should reflect potential to produce a molecular analysis technology with a major impact in cancer-relevant research
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $300,000/year (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-003
R21 NIH

March 17 All Ranks Federal Biospecimen Science

Innovative Technologies for Cancer-Relevant Biospecimen Science

Projects on the inception and early-stage development of technologies addressing issues related to pre-analytical degradation of targeted analytes during collection, processing, handling, and storage of cancer-relevant biospecimens
Due Dates: March 13 (OSR) Ι March 17 (Sponsor) Letter of Intent due 30 days prior to due date
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-004
R33 NIH

March 17 All Ranks Federal Biospecimen Science

Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science

Projects on advanced development and validation of technologies addressing issues related to pre-analytical degradation of targeted analytes during collection, processing, handling, and storage of cancer-relevant biospecimens
Due Dates: March 13 (OSR) Ι March 17 (Sponsor) Letter of Intent due 30 days prior to due date
Amount & Project Period: $300,000/year (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-005


NEW
March 18 Postdocs Non-federal Career Development

Robert Wood Johnson Foundation
Harold Amos Medical Faculty Development Program

Postdoctoral research awards to increase the number of faculty from historically disadvantaged backgrounds who 1) can achieve senior rank in academic medicine and 2) who will encourage and foster the development of succeeding classes of such physicians.
Due Dates: March 16 (OSR) Ι March 18 (Sponsor)
Amount & Project Period: $105,000/year - 4 years
Eligibility: From historically disadvantaged backgrounds (ethnic, financial or educational), 
U.S. citizens or permanent residents, and 
Completing or have completed formal clinical training. (Preference to those having recently completed formal clinical training)
Must spend at least 70% time engaged in research
Contact: Linda Nolan (x6071)
Links: 2015 Call for Applications Ι MyRWJF


NEW
March 18 Jr Faculty Non-federal Stem Cell Research

The New York Stem Cell Foundation
Innovator Awards for Early Career Investigators in Neuroscience

Applications are encouraged in the fundamental areas of developmental, cellular, cognitive and behavioral neuroscience, broadly interpreted.
Due Dates: March 16 (OSR) Ι March 18 (Sponsor)
Amount & Project Period: $300,000/year - 5 years
Eligibility: Early career investigators - Must have terminal degree; Must be w/in 5  years of 1st faculty appointment (as of 6/1/15); Must have publication record of  innovation and high impact
Contact: Linda Nolan (x6071)
Links: Overview  Ι RFP
NEW

Innovator Awards for Early Career Investigators in Translational Stem Cell Research

Exploring the basic biology and translational potential of stem cells and advancing understanding and use of stem cells in the development of treatments for human disease
Due Dates: March 16 (OSR) Ι March 18 (Sponsor)
Amount & Project Period: $300,000/year - 5 years
Eligibility: Early career investigators - Must have terminal degree; Must be w/in 5  years of 1st faculty appointment (as of 6/1/15); Must have publication record of  innovation and high impact
Contact: Linda Nolan (x6071)
RFA Link: Overview  Ι RFP

NEW
March 18 Postdocs Non-federal Bladder Cancer

Bladder Cancer Advocacy Network (BCAN)
John Quale Travel Fellowships

Opportunity for early career investigators interested in bladder cancer research to attend the annual Bladder Cancer Think Tank Meeting August 6-8, 2015 in Charlotte, North Carolina  The primary mission of this meeting is to enhance collaboration among physicians and researchers dedicated to the prevention, diagnosis, and treatment of bladder cancer
Due Dates: March 18 (via Proposal Central)
Amount & Project Period: $1,700 for travel-related costs
Eligibility: MDs & PhDs at post-graduate, pre-faculty level (not begun a faculty appointment as of April 14. MDs must be in final year of residency or in a fellowship program. PhDs must be postdoctoral fellows.
Contact: Linda Nolan (x6071)
Links: Application-Instructions Ι BCAN   

March 19 Jr Faculty Non-federal Brain Cancer

The Sontag Foundation
2015 Distinguished Scientist Awards

For early career scientists with the potential to create new waves across the brain cancer field   Research focus on increased survival rates and improved recovery for patients and a cure or at the very least, treatments to make brain cancer a manageable chronic disease
Due Dates: March 17 (OSR) Ι March 19 (12:00pm - Sponsor)
Amount & Project Period: $150,000/yr - 4 years
Eligibility: Junior faculty in their first independent, full-time faculty appointment (appointed no earlier than March 1, 2012)
Contact: Linda Nolan (X6071)
Link: Applying for the Distinguished Scientist Award
R21 NCI

March 20 All Faculty Federal Clinical Collaborations

Opportunities for Collaborative Research at the NIH Clinical Center

NCI encourages bench-to-bedside research to:  increase understanding of molecular and physiological basis of health and disease; stimulate clinical discoveries about mechanisms underlying disease to develop improved prevention, diagnosis, and treatment; enable translation of basic discoveries into clinical practice to benefit personal and public health; foster training and mentoring of emerging scientists and physicians; and communicate research advances to the public.
Due Dates: March 18 (OSR) Ι March 20 (Sponsor)
Amount & Project Period: $500,000/year (Direct Costs) - 3 years (includes Clinical Center costs and intramural investigator's costs attributed to proposed research*)
*NIH Clinical Center costs and intramural investigator's costs will not be included in the award paid to the grantee
Eligibility: All Faculty - application must include at least one intramural scientist as Program Director/Principal Investigator or collaborator, and some of the research must be conducted at the NIH Clinical Center
Contact: Linda Nolan (x6071)
FOA Link: PAR-13-358
UH2/UH3 NIH
Phase Innovation Awards Cooperative Agreement

March 26 All Ranks Federal Assay Validation

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials

UH2 Phase supports analytical validation of assays for markers that must be achieved in 2 years before an assay may undergo clinical evaluation
Due Dates: March 24 (OSR) Ι March 26 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $275,000 (Direct Costs) - UH2 phase (2 years)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-095
UH3 NIH
Exploratory/Developmental Cooperative Agreement
Phase II
March 26 All Ranks Federal Assay Validation

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials

The UH3 mechanism supports clinical validation of established assays for up to 3 years using specimens from retrospective or prospective studies w/purpose of developing assays to a point where their clinical utility could be assessed in other trials.
Due Dates: March 24 (OSR) Ι March 26 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $250,000/year (Direct Costs) - UH3 phase (3 years)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-096


March 27 Jr Faculty Non-federal Radiation Oncology

American Society for Radiation Oncology

Due Dates: March 25 (OSR) Ι March 27 (Sponsor)
Contact: Linda Nolan (x6071)

Comparative Effectiveness Research Award

To stimulate research focused on evaluating the effectiveness, complication profile, cost and cost-effectiveness of various radiation therapy treatments, as well as the comparative effectiveness when compared to other therapies.
Amount & Project Period: $50,000/year - 2 years
Eligibility: Must be active members of ASTRO
Must be a board-certified or board-eligible physician or physicist in radiation oncology or a radiobiologist at time of award
At least 40% full-time professional effort must be devoted to goals of award
Links: Comparative Effectiveness Award
Award Requirements & Obligations

Junior Faculty Career Research Training Award

Specific areas of interest may include: (1) Basic and clinical research in radiation therapy sciences; (2) Projects developing innovative techniques, new methods or special equipment leading to better patient care; (3) Aspects of health care planning and delivery, including outcome evaluation; (4) Development of programs in health education relevant to radiation therapy sciences
Amount & Project Period: $100,000/year - 2 years
Eligibility: Must be w/in first 3 years of Jr Faculty appointment
Applicants & mentors must be active ASTRO members
At least 75% full-time professional effort must be devoted to goals of award
Links: Jr Faculty Award Ι Award Requirements and Obligations

 Seed Grant

Specific areas of interest may include: (1) Basic and clinical research in radiation therapy sciences; (2) Projects developing innovative techniques, new methods or special equipment leading to better patient care; (3) Aspects of health care planning and delivery, including outcome evaluation; (4) Development of programs in health education relevant to radiation therapy sciences
Amount & Project Period: $25,000 - 1 year
Eligibility: Must be in a U.S. residency or fellowship
Mentors must be active members of ASTRO.
Must not have previously served as PI or co-PI on grants totaling $50,000 or more in a single calendar year
At least 75% full-time professional effort must be devoted to goals of award
Links: Seed Grant Guidelines Ι Award Requirements & Obligations


NEW
March 27 (LOI) All Faculty Federal Patient Safety

Agency for Healthcare Quality and Research
Patient Safety Learning Laboratories: Innovative Design and Development to Improve Healthcare Delivery Systems

For creation and utilization of Patient Safety Learning Laboratories that will enable multiple develop-test-revise iterations of promising design features and subsystems.
Due Dates: March 27 (Letter of Intent)
Applications:  April 23 (OSR) Ι April 27 (Sponsor)
Amount & Project Period: $1,000,000 (TOTAL) - 4 years
Eligibility: All Faculty - Only 1 PD/PI who must commit at least 15% effort per year
Contact: Linda Nolan (x6071)
RFA Link: RFA-HS-15-001
March 31 (LOI) All Ranks Non-federal Internatnl./Interdisciplinary Research

Human Frontier Science Program
2016 Program and Young Investigator Grants

Program and Young Investigator Grants support innovative basic research into fundamental biological problems w/emphasis on novel & interdisciplinary approaches involving scientific exchanges across national and disciplinary boundaries.  Applicants are expected to develop new lines of research through collaboration
Due Dates: March 31 (Letter of Intent)
Invited Submissions:  Mid-September
Registration via HFSP extranet site is required by March 19th 2015 to obtain a reference number (LIXXXXXX/2016)
Amount & Project Period: Team of >4: $450,000/year(Total) - 3 years
Team of 2: $250,000/year (Total) - 3 years
Team of 3: $350,000/year (Total) - 3 years
See addnl. funding information in Guidelines for Applicants
Eligibility: Common to both Grants:
Must have "international research team
Team made up of "members", & 1 is designated as "Principal Applicant"; others: "Co-Applicants"
At least 1 member of international team must have laboratory in a country other than that of the Principal Applicant
Research conducted w/in only 1 country not eligible
Young Investigator:  All team members must be w/in 5 years of obtaining independent position but first doctoral degree (PhD, MD or equivalent) <10 years before deadline for letter of intent. Program Grants:  Principal Applicant must be in a position to initiate/direct independent lines of research; have responsibility for a laboratory and show evidence of independence
Contact: Linda Nolan (x6071)
Links: Information and Guidelines Ι Guidelines for Applicants
R01 NCI

NEW
April 01 All Ranks federal Cancer Epidemiology Cohorts

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts

Targeted infrastructure support of core functions of Cancer Epidemiology Cohorts (CECs) and methodological research Will support infrastructure and core functions for existing or new CECs
Due Dates: March 30 (OSR) Ι April 01 (Sponsor) Letter of Intent due 30 days prior to stated sponsor due date
Amount & Project Period: $2.5M/year (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-104
April 01 All Faculty Federal PCOR-Conference Support

Patient-Centered Outcomes Research Institute    
Engagement Award (EAIN): Research Meeting and Conference Support

Available funding support for meetings and conferences that align with PCORI's Mission and Strategic Plan and facilitate expansion of patient-centered outcomes research/clinical comparative effectiveness research (PCOR/CER)
Applicant Town Hall Sessions: February 17th, 3:00 p.m. - 4:00 p.m. (ET) 
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: One-time award: $50,000 (Total Costs) -1 year
Multi-year award:  $250,000 (Total Costs) - 2 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
Link: Application Information


Annual Due Date
April 01 See Below Non-federal Career Development

American Cancer Society

Due Dates: Mar 30 (OSR) Ι Apr 01 (Sponsor-Electronic) Ι Apr 02 (Hardcopy)
Contact: Linda Nolan (x6071)

Mentored Research Scholar Grant in Applied and Clinical Research

For beginning investigators to become independent as either clinician scientists or cancer control and prevention researchers.
Amount & Project Period: $135,000/year (Direct Costs) - 5 years
Eligibility: Within initial 4 years of first independent appointment
Link: Mentored Research Scholar Grant in Applied and Clinical Research
 

Research Scholar Grants in Basic, Preclinical, Clinical and Epidemiology Research

Supports investigator-initiated research projects in basic, preclinical, clinical and epidemiologic research
Amount & Project Period: $200,000/year (Direct Costs)* - 4 years
Eligibility: Must be independent, self-directed and w/in 6 years of first academic appointment.*
Link: Research Scholar Grants
*Exception for research studies in psychosocial, behavioral, health policy or health services which address cancer health equity and disparities.  Investigators can be at any stage of their career and may request $400,000/year direct costs for up to 5 years.
 

Postdoctoral Fellowships

 Support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer research.
Amount & Project Period: 3-year award with progressive stipends of $48,000, $50,000, and $52,000/year, plus $4,000/year fellowship allowance
Eligibility: Must  be U.S. citizens
Link: Postdoctoral Fellowships

Pilot and Exploratory Studies Using Community-Based Participatory Research (CBPR) to Achieve Cancer Health Equity

To stimulate research on effective interventions to reduce cancer health disparities (at any stage of the cancer continuum) and achieve cancer health equity using community-based participatory research (CBPR).
Amount & Project Period: $100,000 (TOTAL) - 2 years
Eligibility: Independent investigators at all stages of career are eligible
RFP: CBPR Request for Proposals
 

Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

Pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families 
Amount & Project Period: $60,000/year (Direct Costs) - 2 years
Eligibility: Independent investigators at all stages of their career are eligible to apply
RFA Link: Palliative Care Request for Proposals


The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services

A call for research that evaluates the impact of the many changes now occurring in the healthcare system with a particular focus on cancer prevention, control, and treatment Efforts focusing on improving access to care may also impact inequities that contribute to health disparities.
Amount & Project Period: $165,000/year (Direct Costs) - 4 years
$200,000/year (Direct Costs) - 5 years (Health Equity focus only)
Eligibility: Independent investigators at all stages of their career are eligible to apply
Contact: Linda Nolan (x6071)
RFA Link: RFA


April 01 Postdocs Non-federal Career Development

Cancer Research Institute
Irvington Post Doctoral Fellowships

Seeks hypothesis driven, mechanistic studies in both immunology and tumor immunology
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: Stipend of:
      $50,000 Year 01
      $53,000 Year 02
      $57,000 Year 03 and
      $1,500/year for research support
Eligibility: Must have doctoral degree by date of award activation Applicants >5 or more years of relevant postdoctoral experience are not eligible; except M.D. applicants, who should not include years of residency in calculation
No citizenship restrictions
Contact: Linda Nolan, x6071
Links: CRI Grants and Programs Postdoctoral Fellowship Application Guidelines


NEW
April 01 All faculty Non-federal Leukemia

When Everyone Survives (WES) Leukemia Research Foundation
2015 request for Proposals in Leukemia Research

 Laboratory, translational, or clinical research related to acute leukemia
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: $50,000 (Total) - 1 year
Eligibility: All Faculty
Contact: Linda Nolan, x6071
RFP Link: 2015 RFP
U54 NCI
Re-issue of PAR-12-055
NEW FOA Number
April 01 All Ranks federal Health Equity Partnerships

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE)  

 To continue fostering and supporting intensive collaborations among investigators at institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI-designated Cancer Centers (CCs) to develop stronger national cancer programs aimed at understanding reasons behind significant cancer disparities and related impacts on these populations.
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: $2.5M/year (Direct Costs) for dyads
$3.0M/year (Direct costs) for triads - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-103
U01 NCI

NEW
April 09 All Ranks Federal Cancer Care Delivery

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

 1.    Seeks to advance the science of multilevel interventions in 3  ways:
          a) By establishing a common conceptualization of levels  & associated level-specific 
factors that affect practice;
          b) By standardizing metrics of the levels and their main effects on other levels and the individuals needing follow-up care;
          c) By developing and standardizing analysis of the effect of interventions on individuals, groups, and organizations responsible for intervention implementation.
2.     Encourages applications that test interventions to improve the follow-up of abnormal
         screening in one or more ways, including:
          a) measuring multilevel effects of single-level interventions;
          b) comparing single vs. multilevel interventions;
          c) testing multilevel interventions
Due Dates: April 07 (OSR) Ι April 09 (Sponsor) Letter of Intent due 30 days prior to stated sponsor due date
Amount & Project Period: $450,000 to $500,000/year (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Linda Nolan, x6071
FOA Link: PAR-15-108


NEW
April 14 All Faculty Non-federal Health Disparities

Robert Wood Johnson Foundation (RWJF)
Awards for Eliminating Health Disparities  

 Proposals sought to establish annual awards program honoring individuals who implement systems changes to solve health disparities. Program will span 7 years w/first winner selected in 2016. 10 organizations will be chosen to administer the awards programs Organizations must have experience with systems change in one or more of the following areas that influences health outcomes: access to quality health care, education, employment, income, community environment, housing or public safety.
Due Dates: April 10 (OSR) Ι April 14 (Sponsor)  
Applicant Web Conference March 25, 2015 (2 p.m. ET)
Register here.
Amount & Project Period: $60,000 (Total) - 7 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
Link: Overview


Spring Cycle 2015
April 15 Jr Faculty Non-federal Career Development

American Cancer Society Institutional Research Grant (ACS-IRG)
ACS-IRG Pilot Project Funding Opportunities

Pilot funding opportunities to support junior faculty in initiating cancer-related research projects that assist them in competing successfully for national research grants.
Due Dates: April 15 (4:00pm) to Maureen Ahearn
Amount & Project Period: $30,000 - 1 year
Eligibility: Full-time faculty members at Assistant Member/Assistant Professor level or equivalent are eligible
Must be w/in first 6 years of initial faculty appointment
May not have any active peer-reviewed funding at time of submission or award
Research Scientists are eligible to apply. Must be independent and within two years of a tenure-track appointment
Contact: Maureen Ahearn (x8824)
Links: ACS-IRG Application Ι ACS-IRG Guidelines
R35 NIGMS
National Institute of General  Medical Sciences

              NEW
April 20 (LOI) All Ranks Federal Research Support

Maximizing Investigators' Research Award (MIRA)

The MIRA is a grant to provide support for all of the research in an investigator's laboratory that falls within the mission of NIGMS  This FOA will test the feasibility of this grant mechanism through a pilot program with restricted eligibility
Due Dates: April 20 (Letter of Intent)
Applications:  May 18 (OSR) Ι May 20 (Sponsor)
Amount & Project Period: $750,000/year (Direct Costs) - 5 years
Eligibility: Targets investigators who received either >2 R01 equivalent awards or a single award of greater than $400,000 direct costs,  from NIGMS in FY2013 or 2014, and with support for >1 of their awards expiring in FY2016 or 2017.   Other investigators are ineligible.  Only single PD/PI applications are allowed PD/PIs must be able to devote 51% research effort to MIRA
Contact: Linda Nolan (x6071)
RFA Link: RFA-GM-16-002


April 21 Postdocs/Fellows Non-federal Career Development

Multiple Myeloma Research Foundation (MMRF)
Research Fellow Awards

To accelerate development of therapeutic approaches for myeloma; may include proposals in basic science, validation, or clinical research
Due Dates: April 17 (OSR) Ι April 21 (Sponsor)
Amount & Project Period: $75,000 - 1 year
Eligibility: Ph.D., M.D. or equivalent degree at post-doctorate, clinical fellow or assistant professor levels and beginning studies in multiple myeloma field under supervision of a research mentor
Contact: Linda Nolan (x6071)
Links: MMRF Research Grants Ι 2015 Program Guidelines

NEW
May 01 All Ranks Non-federal Cellular and Molecular Imaging in Cancer

Robarts Research Institute
2015 J. Allyn Taylor International Prize in Medicine

This prize is awarded annually to one or more individuals who have made significant contributions in basic or clinical research.  The 2015 Prize will be granted to a scientist who has made outstanding contributions in the area of Cellular and Molecular Imaging in Cancer
Due Dates: May 01
Amount & Project Period: All Ranks
Eligibility: $25,000 - prize
Contact: Linda Nolan (x6071)
Link: Overview
R01 NIH

May 12 All Ranks Federal Prevention-Native Americans

Interventions for Health Promotion and Disease prevention in Native American Populations  

Develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations
Due Dates: May 10 (OSR) Ι May 12 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-14-260


NEW
May 15 (LOI) All Ranks Federal Conference Support - Research Integrity

FY15 Announcement of the Anticipated Availability of Funds for Research Conferences on Research Integrity

Conferences or workshops must be designed to provide a forum for discussion and produce tangible outcomes related to at least one of the following themes:
     1) Responsible conduct of research training;
     2) Fostering an environment promoting research integrity;
     3) Prevention of research misconduct;
     4) Handling of research misconduct allegations;
     5) Whistleblowing;
     6) International issues in research integrity;
     7) Other topics linked to research integrity and compliance
Due Dates: May 13 (OSR) Ι May 15 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: IR-ORI-15-002
U01 NIH

May 17 (LOI) All Faculty Federal Population Science & Cancer

Bridging the Gap Between Cancer Mechanism and Population Science

Any project that poses and addresses a challenging cancer question that can only be addressed by linking these two ends of the cancer spectrum -- biological mechanism and population
Due Dates: May 17 (Letter of Intent) (also Oct. 4th)
June 15 (OSR) Ι June 17 (Sponsor) (also Nov. 4th)
Amount & Project Period: $750,000/yr. (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
FOA Link: PAR-13-081
R21/R33 NCCIH
National Center for
Complementary and
Integrative Health
                NEW
May 22 (LOI) All Ranks Federal Natural Product Testing

Phased Innovation Award for Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics

Supports pilot testing of natural products (i.e., botanicals, dietary supplements, and probiotics), having sufficient early-stage data to justify further clinical testing.  Intention is to speed translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted
Due Dates: May 22 (Letter of Intent)
Applications:  June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Total Direct Costs) - 2 years (R21)
$450,000 (Total Direct Costs) - 3 years (R33)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-AT-16-001


and



Exp. May 28
Int. June 03
All Ranks Federal Healthcare Research

National Science Foundation & National Institutes of Health
Smart and Connected Health (SCH)

The goal of this interagency program is development of next generation health and healthcare research through high-risk, high-reward advances in understanding of and applications in information science, technology, behavior, cognition, sensors, robotics, bio-imaging, and engineering.  Collaboration between academic, industry, non-profit and other organizations is strongly encouraged to establish better linkages between fundamental science, clinical practice and technology development, deployment and use.
Due Dates: Exploratory:  May 26 (OSR) Ι May 28 (Sponsor)
Integrative:
   June 1 (OSR) Ι June 03 (Sponsor)
Amount & Project Period: Exploratory: $170,000/year (Direct Costs) - 3 years
Integrative:  $370,000/year (Direct Costs) - 4 years
Eligibility: All Ranks - An investigator may participate as PI, co-PI, Project Director, Senior Personnel or Consultant in no more than two proposals submitted in response to this solicitation.
Contact: Linda Nolan (x6071)
FOA Link: NSF-13-543
R01 NIH
National Center for Complementary  and Integrative Health       

                 NEW
May 29 (LOI) All Ranks Federal Natural Product Testing

Exploratory Clinical Trials and Studies of Natural Products in NCCIH High Priority Research Topics

Support provided to confirm link between impact of natural product on biological signature (i.e., mechanism of action) and demonstrate an association between change in the biological signature and clinical outcomes. Intention is to speed translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted
Due Dates: May 29 (Letter of Intent)
Applications:  June 25 (OSR) Ι June 29 (Sponsor)
Amount & Project Period: $450,000 (Total Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-AT-16-002




May 29 All Ranks Non-federal Drug Discovery

Sanford Ι Burnham Medical Research Institute
Florida Translational Research Program
2015 Spring Call for Submissions

Concept or assay development projects for use in pre-therapeutic discovery via high-throughput screening - development of innovative biochemical and cell-based assays for biological targets, pathways, or processes for which there are limited selective and potent small molecule modulators available
High-throughput screening (HTS)-ready assays - well-developed, HTS-ready assays suitable for high-throughput screening of the Sanford-Burnham library of compounds for the purpose of identifying small-molecule modulators of the target, pathways, or processes of interest Validated hits for the discovery of pre-therapeutic lead compounds - proposals that aim to further research and development of existing small-molecule chemical scaffolds for use in vivo
Due Dates: May 27 (OSR) Ι May 29 (Sponsor)
Amount & Project Period: No funding - 1 year     Provides access to technological resources for drug development facilitating an interdisciplinary, collaborative approach to the establishment of a pipeline of potential new treatments for today's most challenging and unmet medical needs
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: Florida Translational Research Program at Sanford-Burnham
S10 NIH

May 29 All Ranks Federal Equipment

Shared Instrumentation Grant (SIG) Program

Encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems  Types of instruments supported include: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers
Due Dates: May 27 (OSR) Ι May 29 (Sponsor)
Amount & Project Period: Maximum: $600,000 - 1 year
Eligibility: PD/PI should have documented technical expertise directly related to chosen instrument.
Major User group of 3 or more individuals must be identified. Each must be a PD/PI on a distinct NIH award with one of the following activity codes: R01, DP1, DP2, P01, P50, R37, and U01. Major Users must have substantial interests in and needs for the instrument.
Major Users can be researchers from the same department or from several departments, divisions or schools at applicant institution, or from nearby or regional institutions.
Contact: Christi Craig (x1458)
FOA Link: PAR-15-088


June 01 All Ranks Non-federal Pediatric Brain Cancer

The Cure Starts Now Foundation
Research Grants

Funds search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers Focus is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support translational and clinical research projects in those areas.
Due Dates: May 28 (OSR) Ι June 01 (Sponsor) (Hardcopy by June 5th)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks
Contact: Shaina Sine (x3658)
Link: Research & Grants
R21 NIH

NEW FOA #
June 17 All Ranks federal Health Disparities

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities

Basic research studies into the biological/genetic causes and mechanisms of cancer health disparities
Due Dates: June 15 (OSR) Ι June 17 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-092
R01 NIH

NEW FOA #
June 17 All Ranks federal Health Disparities

Basic Cancer Research in Cancer Health Disparities

To investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention intervention strategies, (2) development & testing of new methodologies & models, and (3) secondary data analyses
Due Dates: June 15 (OSR) Ι June 17 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
PAR Link: PAR-15-093
R21 NIH


NEW FOA #
June 22 All Ranks Federal Career Development

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research

Supports eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences workforce. Provides a bridge to investigators that have completed their research training and may need extra time to develop a larger research project grant application.
Due Dates: June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-053


\
June 30 All Ranks Non-federal Leukemia

Children's Leukemia Research Association, Inc.
Research Grants

Funds the most promising studies to isolate the causes of leukemia 
Due Dates: June 26 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan  (x6071)
Link: Research Grants

NEW
July 01 Jr. Faculty Non-federal Career Development

Damon Runyon Cancer Research Institute 
Innovation Award

To provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding
Due Dates: June 29 (OSR) Ι July 01 (Sponsor) by 4:00pm ET
Amount & Project Period: $150,000/year - 2 years (w/opportunity for up to 2 addnl. years)
Eligibility: Applicants must belong to one of the following:
     Tenure-track Assistant Professors w/in first 4 years of initial
     Assistant Professor position (Cut-off date: July 1, 2011.)
     Clinical Instructors and Senior Clinical Fellows (in final year of
     sub-specialty training) holding an MD and pursuing a period
     of independent research before a tenure-track faculty  
     position. 
     Applicants are expected to commit a minimum of 80% FTE to
     conducting research
Contact: Linda Nolan (x6071)
Links: Overview  Ι  Application Guidelines
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology
Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org